Prevalence of sarcopenia and risk of falling in patients with type 2 Diabetes Mellitus in Primary Health Care
DOI:
https://doi.org/10.11606/issn.2176-7262.rmrp.2026.230540Palabras clave:
Sarcopenia, Diabetes Mellitus, Type 2, Primary Health CareResumen
Objective: To analyze the prevalence of sarcopenia and risk of falls in individuals with type 2 Diabetes Mellitus (T2DM) in Primary Health Care (PHC). Method: A cross-sectional study conducted with adults and older adults with T2DM. Instruments were applied to collect sociodemographic, clinical, and anthropometric data. Sarcopenia was assessed using the questionnaire recommended by the European Working Group on Sarcopenia in Older People (EWGSOP2), and fall risk was assessed using the Falls Efficacy Scale International questionnaire. The association between sarcopenia and fall risk was analyzed using binomial logistic regression. Analyses were performed using Stata 14.0
software. Results: A total of 214 individuals were assessed. The prevalence of sarcopenia was 15.4%, and the prevalence of fall risk was 42.5%. The presence of acute myocardial infarction increased the odds of sarcopenia by 4.07 times (p=0.004), while increased arm circumference reduced this odd by 30% (p=0.000). The presence of sarcopenia increased the odds of falls by 2.48 times (p=0.021), and increased waist circumference reduced the odds of falls by 2%. Conclusion: The prevalence of sarcopenia and falls in this population, particularly among older adults, highlights the need for targeted interventions. Early identification of these conditions and the implementation of preventive strategies may significantly improve quality of life and reduce the negative effects of muscle mass loss.
Descargas
Referencias
1. Hossain MJ, Al-Mamun M, Islam MR. Diabetes mellitus, the fastest growing global public health concern: Early detection should be focused. Health Sci Rep. 2024;7(3):e2004. doi: 10.1002/hsr2.2004
2. Muzy J, Campos M, Emmerick I, Avelar FG. Caracterização da atenção ao paciente com diabetes na atenção primária a partir do PMAQ-AB. Cien Saude Colet. 2022;27(9). doi: 10.1590/1413-81232022279
3. Izzo A, Massimino E, Riccardi G, Della Pepa G. A Narrative Review on Sarcopenia in Type 2 Diabetes Mellitus: Prevalence and Associated Factors. Nutrients. 2021;13(1):183. doi: 10.3390/nu13010183
4. Sravya SL, Swain J, Sahoo AK, Mangaraj S, Kanwar J, Jadhao P, et al. Sarcopenia in Type 2 Diabetes Mellitus: Study of the Modifiable Risk Factors Involved. J Clin Med. 2023;12(17):5499. doi: 10.3390/jcm12175499
5. Sanz-Cánovas J, López-Sampalo A, Cobos-Palacios L, Ricci M, Hernández-Negrín H, Mancebo-Sevilla JJ, et al. Management of type 2 diabetes mellitus in elderly patients with frailty and/or sarcopenia. Int J Environ Res Public Health. 2022;19(14):8677. doi: 10.3390/ijerph1914867
6. Nascimento PRC, Bilodeau M, Poitras S. How do we define and measure sarcopenia? A meta-analysis of observational studies. Age Ageing. 2021;50(6):1906-13. doi: 10.1093/envelhecimento/afab148
7. Yuan S, Larsoon SC. Epidemiology of sarcopenia: Prevalence, risk factors, and consequences. Metabolism. 2023; 144:155533. doi: 10.1016/j.metabol.2023.1555
8. Rodrigues AAGDS, Peixoto Junior AA, Borges CL, Soares ES, Lima JWDO. Prevalência dos componentes da sarcopenia e fatores socioeconômicos associados em idosos de uma população rural do estado do Ceará, Brasil. Cien Saude Colet. 2023;28:3159-68. doi: 10.1590/1413-812320232811.17642022
9. Freitas MM, Oliveira VLP, Grassi T, Valduga, K, Miller MEP, Schuchmann RA, et al. Difference in sarcopenia prevalence and associated factors according to 2010 and 2018 European consensus (EWGSOP) in elderly patients with type 2 diabetes mellitus. Exp Gerontol. 2020;132: 110835. doi: 10.1016/j.exger.2020.110835
10. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al. European Working Group on Sarcopenia in Older People. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010;39(4):412-23. doi: 10.1093/envelhecimento/afq034
11. Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T, et al. Writing Group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2), and the Extended Group for EWGSOP2. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16-31.doi: 10.1093/envelhecimento/afy169
12. Sousa CR, Coutinho JFV, Marques MB, Barbosa RGB, Roriz Filho JS, Soares ES, et al. Prevalence of characteristics associated with sarcopenia in elders: a cross-sectional study. Rev Bras Enferm. 2023;76(2):e20220209. doi: 10.1590/0034-7167-2022-0209
13. Matsudo S, Araújo T, Marsudo V, Andrade D, Andrade E, Oliveira LC, Braggion G. Questionário Internacional de Atividade Física (IPAQ): Estudo de validade e reprodutibilidade no Brasil. Sociedade Brasileira de Atividade Física e Saúde. 2001;6(2):5-18. doi: 10.12820/rbafs.v.6n2p5-18
14. Roberts-Lewis SF, White CM, Ashworth M, Rose MR. The validity of the International Physical Activity Questionnaire (IPAQ) for adults with progressive muscle diseases. Disabil Rehabil. 2022;44(23):7312-20. doi: 10.1080/09638288.2021.1983042
15. Barbosa-Silva TG, Menezes AMB, Bielemann RM, Malmstrom TK, Gonzalez MC. Enchancing SARC-F: improving sarcopenia screening in the clinical practice. J Am Med Dir Assoc. 2016;17(12):1136-41. doi: 10.1016/j.jamda.2016.08.004
16. Camargos F, Dias R, Dias J, Freire M. Adaptação transcultural e avaliação das propriedades psicométricas da Falls Efficacy Scale - International em idosos brasileiros (FES-I-BRASIL). Braz J Phys Ther. 2010;14(3):237-43. doi: https://doi.org/10.1590/S1413-35552010000300010
17. Ministério da Saúde (Brasil). Portaria SCTIE/MS Nº 53, de 11 de novembro de 2020. Protocolo Clínico e Diretrizes Terapêuticas de Sobrepeso e Obesidade em Adultos. Disponível em: http://conitec.gov.br/
18. Schaper NC, van Netten JJ, Apelqvist J, Bus SA, Fitridge R, Game F, et al. IWGDF Editorial Board. Practical guidelines on the prevention and management of diabetes-related foot disease (IWGDF 2023 update). Diabetes Metab Res Rev. 2024;40(3):e3657. doi: 10.1002/dmrr.3657.
19. Dent E, Morley JE, Cruz-Jentoft AJ, Arai H, Kritchevsky SB, Guralnik J, et al. International Clinical Practice Guidelines for Sarcopenia (ICFSR): Screening, Diagnosis and Management. J Nutr Health Aging. 2018;22(10):1148-61. doi: 10.1007/s12603-018-1139-9
20. Purnamasari D, Tetrasiwi EN, Kartiko GJ, Astrella C, Husam K, Laksmi PW. Sarcopenia and Chronic Complications of Type 2 Diabetes Mellitus. Rev Diabet Stud. 2022;18(3):157-165. doi: 10.1900/RDS.2022.18.157
21. Yang Q, Ni X, Zhang Y, Zhu B, Zeng Q, Yang C, et al. Sarcopenia is an independent risk factor for all-cause mortality rate in patients with diabetic foot ulcers. Front. Nutr. 2023; 10:1097008. doi: 10.3389/fnut.2023.1097008
22. Damluji AA, Alfaraidhy M, AlHajri N, Rohant NN, Kumar M, Al Malouf C. Sarcopenia and Cardiovascular Diseases. Circulation. 2023;147(20):1534-53. doi: 10.1161/CIRCULATIONAHA.123.064071
23. Shen Y, Shi Q, Nong K, Li S, Yue J, Huang J, et al. Exercise for sarcopenia in older people: A systematic review and network meta-analysis. J Cachexia Sarcopenia Muscle. 2023;14(3):1199-211. doi: 10.1002/jcsm.13225
24. Fayh APT, Guedes FFO, Calado GCF, Queiroz SA, Anselmo MGGB, Sousa IM. SARC-F is a predictor of longer LOS and hospital readmission in hospitalized patients after a cardiovascular event. Nutrients. 2022;14(15):3154. doi: 10.3390/nu14153154
25. Boonpor J, Pell JP, Ho FK, Celis-Morales C, Gray SR. In people with type 2 diabetes, sarcopenia is associated with the incidence of cardiovascular disease: A prospective cohort study from the UK Biobank. Diabetes Obes Metab. 2024;26(2):524-31. doi: 10.1111/dom.15338
26. Chew STH, Tey SL, Yalawar M, Liu Z, Baggs G, How CH, et al. Prevalence and associated factors of sarcopenia in community-dwelling older adults at risk of malnutrition. BMC Geriatr. 2022 Dec 24;22(1):997. doi: 10.1186/s12877-022-03704-1
27. Zhang X, Huang P, Dou Q, Wang C, Zhang W, Yang Y et al. Falls among older adults with sarcopenia dwelling in nursing home or community: A meta-analysis. Clin Nutr. 2020;39(1):33-9. doi: 10.1016/j.clnu.2019.01.002
28. Rodrigues F, Domingos C, Monteiro D, Morouço P. A Review on Aging, Sarcopenia, Falls, and Resistance Training in Community-Dwelling Older Adults. Int J Environ Res Public Health. 2022;19(2):874. doi: 10.3390/ijerph19020874
29. Petermann-Rocha F, Balntzi V, Gray SRG, Lara J, KHo, Pell JP, Celis-Morales C. Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta-analysis. J Cachexia Sarcopenia Muscle. 2022; 13: 86–99. doi: 10.1002/jcsm.12783
30. Gielen E, Beckwée D, Delaere A, De Breucker S, Vandewoude M, Bautmans I. Sarcopenia Guidelines Development Group of the Belgian Society of Gerontology and Geriatrics (BSGG). Nutritional interventions to improve muscle mass, muscle strength, and physical performance in older people: an umbrella review of systematic reviews and meta-analyses. Nutr Rev. 2021;79(2):121-147. doi: 10.1093/nutrit/nuaa011
31. González-Colaço Harmand M, Tejera Concepción A, Farráis Expósito FJ, Domínguez González J, Ramallo-Fariña Y. Pilot Study on the Relationship between Malnutrition and Grip Strength with Prognosis in Diabetic Foot. Nutrients. 2023; 15(17):3710. doi: 10.3390/nu15173710
Descargas
Publicado
Número
Sección
Licencia
Derechos de autor 2026 Lorena Queiroz Rachid, Juliana Mara Flores Bicalho, Andreza Oliveira Henriques Cortez, Viviane Sahade Souza, Daniel Nogueira Cortez

Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.



